LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.764_776delinsCAGAGTACCC
PTEN
· NP_000305.3:p.(Val255_His259delinsAlaGluTyrPro)
· NM_000314.8
GRCh37: chr10:89717739 TAGAGTTCTTCCA>CAGAGTACCC
·
GRCh38: chr10:87957982 TAGAGTTCTTCCA>CAGAGTACCC
Gene:
PTEN
Transcript:
NM_000314.8
Final call
VUS
PM2 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Val255_His259delinsAlaGluTyrPro)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1.
2
VUS: PM2 supporting alone does not satisfy a PTEN pathogenic or benign combination rule.
Final determination:
Under the ClinGen PTEN Expert Panel Version 3.2 combining rules, PM2 at supporting strength alone does not satisfy any pathogenic or benign rule, so the classification is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: the exon 7 in-frame indel is outside the PTEN VCEP decision tree's covered null, splice-site, exon-deletion, duplication, and initiation-codon variant classes. |
cspec
vcep_pvs1_decisiontree_pten
pvs1_variant_assessment
|
| PS1 | Not assessed | Not assessed: no qualifying pathogenic comparator was identified for the complex p.(Val255_His259delinsAlaGluTyrPro) change. |
cspec
pm5_candidates
|
| PS2 | Not assessed | Not assessed: no proband disease status, family-history information, or confirmed maternity and paternity is documented for the required de novo observation. |
cspec
|
| PS3 | Not assessed | Not assessed: mmc2.xlsx contains no exact row for the in-frame delins, so no VCEP-qualified phosphatase activity or high-confidence cumulative score is available. |
cspec
vcep_mmc2
PMID:29706350
|
| PS4 | Not assessed | Not assessed: no affected/control counts, odds ratio, confidence interval, or PTEN phenotype-specific proband scores are available to evaluate PS4. |
cspec
|
| PM1 | Not met | Not met: residues 255-259 lie outside all VCEP-approved catalytic motifs 90-94, 123-130, and 166-168, with no reported hotspot. |
cspec
hotspots
|
| PM2 | Met | Met at supporting strength: the variant is absent from gnomAD v2.1 and v4.1, satisfying the VCEP's <0.00001 (0.001%) population-frequency requirement. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the PTEN VCEP Version 3.2 CSPEC explicitly designates PM3 as not applicable. |
cspec
|
| PM4 | Not met | Not met: residues 255-259 are altered, but the PTEN VCEP PM4 gate requires an in-frame indel to affect catalytic motifs 90-94, 123-130, or 166-168. |
cspec
pvs1_variant_assessment
|
| PM5 | N/A | Not applicable: the variant is an in-frame indel spanning residues 255-259, whereas the VCEP PM5 rule requires a missense change. |
cspec
pm5_candidates
|
| PM6 | Not assessed | Not assessed: no assumed de novo observation, proband disease status, or no-family-history documentation is available for PM6 evaluation. |
cspec
|
| PP1 | Not assessed | Not assessed: zero affected-family-member segregation observations and zero documented meioses are available to compare with the VCEP thresholds. |
cspec
|
| PP2 | N/A | Not applicable: PP2 requires a missense variant, but this variant is an in-frame indel affecting residues 255-259. |
cspec
|
| PP3 | N/A | Not applicable: this is an in-frame indel, whereas PTEN PP3 names only splicing concordance or missense REVEL > 0.7. |
cspec
|
| PP4 | N/A | Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 Use 2 rather than allowing independent PP4 application. |
cspec
|
| PP5 | N/A | Not applicable: the PTEN VCEP explicitly prohibits use of PP5 under its specification. |
cspec
|
| BA1 | Not met | Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than exceeding the VCEP's 0.00056 (0.056%) threshold. |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: no gnomAD allele frequency is observed, whereas BS1 Strong requires 0.000043-0.00056 (0.0043%-0.056%). |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD reports absence and provides no homozygous observation or parental-confirmation data required by the VCEP. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: mmc2.xlsx contains no exact row for the in-frame delins, so no VCEP-qualified phosphatase activity above zero or high-confidence benign assay result is available. |
cspec
vcep_mmc2
PMID:29706350
|
| BS4 | Not assessed | Not assessed: no affected family member with genotype and phenotype data is documented, so lack of segregation in one or more families cannot be determined. |
cspec
|
| BP1 | N/A | Not applicable: the PTEN VCEP explicitly marks BP1 as not applicable. |
cspec
|
| BP2 | Not assessed | Not assessed: zero affected-proband or cis/trans observations with a different pathogenic or likely pathogenic PTEN variant are available. |
cspec
clinvar
|
| BP3 | N/A | Not applicable: the PTEN VCEP explicitly states that BP3 is not applicable to PTEN. |
cspec
|
| BP4 | N/A | Not applicable: this is an in-frame indel, whereas PTEN BP4 names only splicing concordance or missense REVEL < 0.5. |
cspec
|
| BP5 | Not assessed | Not assessed: no two cases with an alternate highly penetrant molecular diagnosis and non-overlapping PTEN histories are documented. |
cspec
|
| BP6 | N/A | Not applicable: the PTEN VCEP explicitly prohibits use of BP6 under its specification. |
cspec
|
| BP7 | N/A | Not applicable: BP7 covers synonymous or intronic variants at or beyond +7/-21, not this exonic in-frame indel. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.